| Authors: |
Weyenga H; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Nairobi, Kenya, National Tuberculosis, Leprosy, and Lung Disease Program, Ministry of Health, Nairobi, Kenya., Onyango E; National Tuberculosis, Leprosy, and Lung Disease Program, Ministry of Health, Nairobi, Kenya., Katana AK; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Nairobi, Kenya., Pathmanathan I; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Sidibe K; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Shah NS; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Ngugi EW; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Nairobi, Kenya., Waruingi RN; College of Health Sciences, University of Nairobi, Nairobi, Kenya., Ng Ang A L; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Nairobi, Kenya., De Cock KM; Division of Global HIV&TB, US Centers for Disease Control and Prevention, Nairobi, Kenya. |